SCHEMBL1440306

SCHEMBL1440306

[CH2]C1OC(=O)OC1C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL126552 0.82
SCHEMBL12389693 0.82
SCHEMBL4954990 0.73
SCHEMBL19784270 0.68
SCHEMBL11990743 0.68
SCHEMBL11990749 0.68
SCHEMBL20365807 0.68
SCHEMBL253455 0.67
SCHEMBL5249010 0.67 SUCNR1 (0.33)
SCHEMBL18787476 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090192129-A1 BICYCLIC PYRROLE DERIVATIVES DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2009-07-30 US claimed
US-20080318922-A1 Bicyclic Pyrrole Derivatives DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2008-12-25 US claimed
EP-1829877-A1 BICYCLIC PYRROLE DERIVATIVES Dainippon Sumitomo Pharma Co., Ltd. (JP) 2007-09-05 EP claimed
EP-3154594-A1 FAP-ACTIVATED THERAPEUTIC AGENTS, AND USES RELATED THERETO Trustees Of Tufts College (US) 2017-04-19 EP disclosed
WO-2015192123-A1 FAP-ACTIVATED THERAPEUTIC AGENTS, AND USES RELATED THERETO TRUSTEES OF TUFTS COLLEGE (US) 2015-12-17 WO disclosed
WO-2015192124-A1 FAP-ACTIVATED THERAPEUTIC AGENTS, AND USES RELATED THERETO TRUSTEES OF TUFTS COLLEGE (US) 2015-12-17 WO disclosed
EP-2919785-A2 ANTIVIRAL AZASUGAR-CONTAINING NUCLEOSIDES Biocryst Pharmaceuticals, Inc. (US) 2015-09-23 EP disclosed
EP-2838535-A1 COMPOSITIONS AND METHODS FOR INHIBITING VIRAL POLYMERASE Biocryst Pharmaceuticals, Inc. (US) 2015-02-25 EP disclosed
WO-2014078778-A2 ANTIVIRAL AZASUGAR-CONTAINING NUCLEOSIDES BIOCRYST PHARMACEUTICALS, INC. (US) 2014-05-22 WO disclosed
WO-2013158746-A1 COMPOSITIONS AND METHODS FOR INHIBITING VIRAL POLYMERASE BIOCRYST PHARMACEUTICALS, INC. (US) 2013-10-24 WO disclosed
EP-2440212-A1 COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF CORONARY HEART DISEASES Generex Pharmaceuticals, Inc. (CN) 2012-04-18 EP disclosed
WO-1999038844-A1 METHOD FOR PREPARING AN N-[(ALIPHATIC OR AROMATIC)CARBONYL]-2-AMINOACETAMIDE COMPOUND AND A CYCLYZED COMPOUND AVENTIS PHARMACEUTICALS PRODUCTS INC. (US) 1999-08-05 WO disclosed
WO-1999031049-A1 NEUROPROTECTIVE AGENTS UNIVERSITY OF SOUTHAMPTON (GB) 1999-06-24 WO disclosed
EP-0794789-A4 INHIBITORS OF PRENYL TRANSFERASES UNIV PITTSBURGH (US) 1999-05-26 EP disclosed
EP-0910571-A2 NOVEL ANTIANGIOGENIC PEPTIDES, POLYPEPTIDES ENCODING SAME AND METHODS FOR INHIBITING ANGIOGENESIS Abbott Laboratories (US) 1999-04-28 EP disclosed
WO-1998050031-A1 INHIBITORS OF PROTEIN ISOPRENYL TRANSFERASES UNIVERSITY OF PITTSBURGH (US) 1998-11-12 WO disclosed
WO-1998050030-A1 INHIBITORS OF PROTEIN ISOPRENYL TRANSFERASES UNIVERSITY OF PITTSBURGH (US) 1998-11-12 WO disclosed
WO-1997041824-A2 ANTIANGIOGENIC PEPTIDES DERIVED FROM PLASMINOGEN ABBOTT LABORATORIES (US) 1997-11-13 WO disclosed
EP-0794789-A1 INHIBITORS OF PRENYL TRANSFERASES UNIVERSITY OF PITTSBURGH (US) 1997-09-17 EP disclosed
WO-1997011080-A1 SUBSTITUTED THIOL MACROLACTAM IMMUNOMODULATORS ABBOTT LABORATORIES (US) 1997-03-27 WO disclosed